Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
PRODUCT INTRODUCTION
Ramiven 50mg Tablet is a medication used in the treatment of metastatic breast cancer. Its function is to impede the growth of cancer cells, eventually leading to their destruction. By doing so, it alleviates symptoms associated with breast cancer, such as the presence of breast lumps, bloody discharge from nipples, or alterations in breast shape.
Ramiven 50mg Tablet can be consumed with or without food and is typically administered alongside another medication. The duration of treatment varies depending on individual requirements and responses. It is crucial to adhere to the exact dosage and duration as prescribed by your doctor. Regular blood tests may be necessary during the course of this medication.
USES OF RAMIVEN TABLET
Metastatic breast cancer
BENEFITS OF RAMIVEN TABLET
In the context of metastatic breast cancer:
Ramiven 50mg Tablet effectively combats breast cancer and can be utilized either as a standalone treatment or in conjunction with other medications or therapeutic approaches, such as chemotherapy. It is employed when other treatments have not yielded significant improvement and the cancer has metastasized. This medication alleviates symptoms associated with breast cancer, such as breast lumps, bloody discharge from nipples, or changes in breast shape or texture. Ramiven 50mg Tablet achieves its therapeutic effect by either destroying cancer cells or inhibiting their proliferation. If you experience any side effects, it's advisable to discuss them with your doctor.
MECHANISM OF ACTION OF RAMIVEN TABLET
Ramiven 50mg Tablet functions by obstructing the activity of an aberrant protein responsible for stimulating the proliferation of cancer cells. This action impedes or prevents the dissemination of cancer cells within the body.